Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22-Reference-Cited by-同舟云学术

Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22

Published:2016-06-02 Issue:8 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Abikhair Melody,Mitsui Hiroshi,Yanofsky Valerie,Roudiani Nazanin,Ovits Channa,Bryan Teddy,Oberyszyn Tatiana M.,Tober Kathleen L.,Gonzalez Juana,Krueger James G.,Felsen Diane,Carucci John A.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Skin cancer is among the most costly of all cancers to treat for the Medicare population

2. Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012

3. Clinicopathologic Variants of Cutaneous Squamous Cell Carcinoma

4. Progress in Dermatology

5. Skin cancer in Australian heart transplant recipients

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of IL-22 in cancer;Medical Oncology;2024-09-05

2. Skin Cancer Precursors;Hematology/Oncology Clinics of North America;2024-08

3. RORγt inverse agonist TF-S14 inhibits Th17 cytokines and prolongs skin allograft survival in sensitized mice;Communications Biology;2024-04-12

4. Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events;Pharmaceuticals;2023-11-15

5. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients;Cells;2023-10-11